Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0000902664-18-001420 0001365341 XXXXXXXX LIVE 8 Common stock, par value $1.00 per share 03/10/2025 false 0001034670 052800109 AUTOLIV INC 3350 AIRPORT RD OGDEN UT 84405 Norma O'Sullivan 4401534828513 Cevian Capital II GP Limited Whiteley Chambers, Don Street St. Helier Y9 JE2 4TR Ele Klein & Adriana Schwartz 212-756-2000 Schulte Roth & Zabel LLP 919 Third Avenue New York NY 10022 0001365341 N Cevian Capital II GP LTD AF N Y9 9319667.00 0.00 9319667.00 0.00 9319667.00 N 12.02 IA OO Includes 3,021,159 Swedish Depositary Receipts representing 3,021,159 shares of Common Stock. Common stock, par value $1.00 per share AUTOLIV INC 3350 AIRPORT RD OGDEN UT 84405 This Amendment No. 8 ("Amendment No. 8") amends and supplements the statement on Schedule 13D filed with the Securities and Exchange Commission on March 1, 2018 (the "Original Schedule 13D", and the Original Schedule 13D as amended, the "Schedule 13D"), with respect to the common stock, par value $1.00 per share (the "Common Stock"), of Autoliv, Inc., a Delaware corporation (the "Issuer"). This Amendment No. 8 amends Items 5(a)-(c) as set forth below. Capitalized terms used herein and not otherwise defined in this Amendment No. 8 have the meanings set forth in the Schedule 13D. See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of shares of Common Stock and percentages of the shares of Common Stock beneficially owned by the Reporting Person. The percentage used in this Schedule 13D is calculated based upon 77,535,354 shares of Common Stock outstanding, which is the difference obtained by (x) subtracting a total of 186,477 shares of Common Stock repurchased by the Issuer on March 3, 2025, March 4, 2025, March 5, 2025, March 6, 2025 and March 7, 2025, under the Issuer's share buyback program as disclosed on the Issuer's website, from (y) 77,721,831 shares of Common Stock outstanding as of February 28, 2025, as disclosed on the Issuer's website. See rows (7) through (10) of the cover pages to this Schedule 13D for the number of shares of Common Stock as to which the Reporting Person has the sole power to vote or direct the vote and sole power to dispose or to direct the disposition. No transactions in the shares of Common Stock or Swedish Depositary Receipts by the Reporting Person for the benefit of the Master Fund were made during the past sixty (60) days. Cevian Capital II GP LTD /s/ Norma O'Sullivan Norma O'Sullivan, Director 03/12/2025